TrialReader


TolerUp Enteral Feeding Protocol

NCT03648255 — Completed, 133 participants, Abbott Nutrition

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

A Prospective, Observational Study to Evaluate Gastrointestinal Symptoms and Safety of an Enteral Feeding Product in Pediatric Patients With Cerebral Palsy

RegistryNCT03648255
StatusCompleted
Study typeObservational
Enrollment133 (Actual)
SponsorAbbott Nutrition (Industry)
ConditionsGastrointestinal Tolerance
Datesstart 2018-02-19, primary completion 2020-07-20, completion 2020-07-20, first posted 2018-08-27, last updated 2020-11-03
Locations19 sites in Turkey (Türkiye)

Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Gastrointestinal Tolerance

-Summary

This prospective, observational, multi-center study will follow children with cerebral palsy who decided to switch to an enteral product that contains partially hydrolyzed protein and medium chain triglycerides as a result of clinical symptoms/diagnosis of gastrointestinal intolerance.

Expand all sections  ·  Collapse all

+Outcome measures

Primary outcomes

  • Gastro-Intestinal Tolerance [Baseline to 6 months]: healthcare professional assessed

Secondary outcomes

  • Anthropometrics [Baseline to 6 months]: change in weight from baseline measurement
  • Care Giver Satisfaction of Enteral Product [Baseline to 6 months]: survey administered by healthcare professional

+Eligibility

Sex: All, ages: 1 Year to 12 Years

Inclusion Criteria:

* Diagnosis of cerebral palsy
* Fed with an enteral product that does not contain partially hydrolyzed protein and medium chain triglycerides and decided to be switched to an enteral product contains partially hydrolyzed protein and medium chain triglycerides as a result of clinical symptoms/diagnosis of gastrointestinal intolerance
* Fed by tube, using enteral tube feeding as sole source of nutrition
* A signed and dated informed consent by subject's legally acceptable representative

Exclusion Criteria:

* Chronic diseases other than cerebral palsy (e.g. diabetes mellitus, renal, liver, endocrine diseases, malignancy)
* Intestinal obstruction
* Dialysis treatment
* Requirement of artificial ventilation
* Requirement of parenteral nutrition
* Normal nutrition in addition to enteral tube feeding
* Allergy or intolerance to any ingredient of the study product
* Currently participating in another clinical or non-clinical study

+Locations (19)

FacilityCityCountryStatus
Çukurova University Medical FacultyAdanaTurkey (Türkiye)
Hacettepe Üniversitesi University Medical FacultyAnkaraTurkey (Türkiye)
Ankara Dışkapı Child Disease HospitalAnkaraTurkey (Türkiye)
Gazi University Medical FacultyAnkaraTurkey (Türkiye)
Ankara University Medical FacultyAnkaraTurkey (Türkiye)
Bursa Yüksek İhtisas Research and Training HospitalBursaTurkey (Türkiye)
Pamukkale Üniversitesi University Medical FacultyDenizliTurkey (Türkiye)
Elazığ University Medical FacultyElâzığTurkey (Türkiye)
Eskişehir Osmangazi University Medical FacultyEskişehirTurkey (Türkiye)
Koç University Medical FacultyIstanbulTurkey (Türkiye)
İstanbul Kanuni Sultan Süleyman Research and Training HospitalIstanbulTurkey (Türkiye)
İstanbul Şişli Hamidiye Etfal Research and Training HospitalIstanbulTurkey (Türkiye)
İstanbul Ümraniye Research and Training HospitalIstanbulTurkey (Türkiye)
İzmir Behçet Uz Child Disease HospitalIzmirTurkey (Türkiye)
Kırıkkale University Medical FacultyKirikkaleTurkey (Türkiye)
Kocaeli Üniversitesi University Medical FacultyKocaeliTurkey (Türkiye)
İnönü Üniversitesi University Medical FacultyMalatyaTurkey (Türkiye)
Ondokuz Mayıs University Medical FacultySamsunTurkey (Türkiye)
Karadeniz Teknik University Medical FacultyTrabzonTurkey (Türkiye)

+Investigators

  • Aysugül Alptekin, MD, Study chair, Abbott Turkey

My Notes